1. Superior vena cava syndrome caused by a swollen absorbable haemostat after repair of ischaemic mitral regurgitation.
- Author
-
Eto K, Matsumoto M, Kubo Y, and Kemmochi R
- Subjects
- Aged, 80 and over, Cellulose, Oxidized therapeutic use, Coronary Artery Bypass methods, Diagnosis, Differential, Echocardiography, Female, Hematoma diagnosis, Humans, Mitral Valve Insufficiency complications, Myocardial Ischemia complications, Postoperative Hemorrhage complications, Superior Vena Cava Syndrome diagnosis, Tomography, X-Ray Computed, Cellulose, Oxidized adverse effects, Heart Valve Prosthesis Implantation methods, Hematoma complications, Mitral Valve Insufficiency surgery, Myocardial Ischemia surgery, Postoperative Hemorrhage prevention & control, Superior Vena Cava Syndrome etiology
- Abstract
Surgicel, an absorbable haemostat, is widely used in cardiovascular surgery. An 81-year-old woman, who was diagnosed with ischaemic mitral regurgitation, underwent mitral valve plasty and coronary artery bypass grafting. On postoperative day two, her superior vena cava (SVC) pressure gradually rose to 38 mmHg and she developed low output syndrome. Emergent surgery revealed that the cause of SVC syndrome was external compression from a haematoma at the posterior surface of the SVC, which formed around the Surgicel.
- Published
- 2014
- Full Text
- View/download PDF